YULEIDYS CRUZ: Open Payments
NPI 1841938792 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 7 payments from 5 companies in 2025. Trend: 2023 $303 · 2024 $685 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $144 |
| SANOFI-AVENTIS U.S. LLC | 2 | $68 |
| Janssen Biotech, Inc. | 1 | $33 |
| Blueprint Medicines Corporation | 1 | $25 |
| Legend Biotech USA Inc. | 1 | $14 |
Products named: CALQUENCE, REZUROCK, DARZALEX, AYVAKIT, LYNPARZA, CARVYKTI.
Industry payments across FL — which companies pay providers there.
